ID   KMRM-S2
AC   CVCL_4W62
DR   Wikidata; Q54900161
RX   PubMed=23379954;
CC   Population: Japanese.
CC   Doubling time: 51 hours (PubMed=23379954).
CC   Karyotypic information: Hypertriploid karyotype. Has lost chromosome Y (PubMed=23379954).
CC   Derived from site: Metastatic; Head, skin; UBERON=UBERON_0001084.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
RX   PubMed=23379954; DOI=10.1111/iju.12084;
RA   Karashima T., Fukuhara H., Tamura K., Ashida S., Kamada M., Inoue K.,
RA   Taguchi T., Kuroda N., Shuin T.;
RT   "Expression of angiogenesis-related gene profiles and development of
RT   resistance to tyrosine-kinase inhibitor in advanced renal cell
RT   carcinoma: characterization of sorafenib-resistant cells derived from
RT   a cutaneous metastasis.";
RL   Int. J. Urol. 20:923-930(2013).
//